EGFR and cancer: In this study, we used an antibody targeting the epidermal growth factor receptor (EGRF) labelled with the alpha emitter 213Bi (213Bi-anti-EGFR-MAb), to explore treatment associated responses in two different cancer cell lines expressing EGRF.